Xenon April 13, 2017 Xenon Trade Name Orphan Indication Ischaemia reperfusion injury associated with cardiac arrest EU Market Approval EU EU Designation Date 2016-10-14 00:00:00 Sponsor Neuroprotexeon Ltd
